Singapore, April 21 -- Santen Pharmaceutical Co. has announced that Santen China has entered into a distribution and promotion agreement with AbbVie for five marketed glaucoma eyedrops in the Chinese Mainland.

Under the agreement, Santen China will receive exclusive distribution rights and conduct promotional activities in the Chinese Mainland for Glaucoma Eyedrops Alphagan(R), AlphaganP(R), Lumigan(R), Ganfort(R) and Combigan(R).

Published by HT Digital Content Services with permission from BioSpectrum Asia....